In: Economics
A pharmaceutical company developed four investment plans. The initial investment and the corresponding annual cash flows of the four investment plans for consecutive 5 years are shown in the following Table Q1.
| Project Name | I | II | III | IV | 
| Initial Investment (OMR) | 58000 | 68000 | 97000 | 119000 | 
| Annual Cash inflow (OMR) | 16000 | 23000 | 29000 | 35000 | 
Identify the best project and decide the ranking based on the following profitability methods.
a) Average rate of return.
b) Payback period.
c) Net Present value with discounting rate at 8%
d) Benefit to cost ratio with discounting rate at 11%
e) Internal rate of return for range of suitable discounting rate
Here,
| I | II | III | IV | |
| Initial Investment | 58000 | 68000 | 97000 | 119000 | 
| Annual Cash Inflow | 16000 | 23000 | 29000 | 35000 | 
Average Rate of Return calculation, using XIRR function in excel
| I | II | III | IV | ||
| 28-05-2020 | Year 0 | -58000 | -68000 | -97000 | -119000 | 
| 28-05-2021 | Year 1 | 16000 | 23000 | 29000 | 35000 | 
| 28-05-2022 | Year 2 | 16000 | 23000 | 29000 | 35000 | 
| 28-05-2023 | Year 3 | 16000 | 23000 | 29000 | 35000 | 
| 28-05-2024 | Year 4 | 16000 | 23000 | 29000 | 35000 | 
| 28-05-2025 | Year 5 | 16000 | 23000 | 29000 | 35000 | 
| Rate of Return | 11.77% | 20.52% | 15.09% | 14.40% | 
Ranking, II>III>IV>I
Payback period = Initial investment / yearly benefits
| I | II | III | IV | |
| Initial Investment | 58000 | 68000 | 97000 | 119000 | 
| Annual Cash Inflow | 16000 | 23000 | 29000 | 35000 | 
| Payback period | 3.625 | 2.956522 | 3.344828 | 3.4 | 
Ranking II>III>IV>I
Present Value using XNPV Function
| Discounting Rate | 8% | ||||
| I | II | III | IV | ||
| 28-05-2020 | Year 0 | -58000 | -68000 | -97000 | -119000 | 
| 28-05-2021 | Year 1 | 16000 | 23000 | 29000 | 35000 | 
| 28-05-2022 | Year 2 | 16000 | 23000 | 29000 | 35000 | 
| 28-05-2023 | Year 3 | 16000 | 23000 | 29000 | 35000 | 
| 28-05-2024 | Year 4 | 16000 | 23000 | 29000 | 35000 | 
| 28-05-2025 | Year 5 | 16000 | 23000 | 29000 | 35000 | 
| Net Present Value | 5878.59 | 23825.47 | 18779.94 | 20734.41 | 
Ranking II>IV>III>I
Benefit to Cost Ratio
| Discounting Rate | 11% | ||||
| I | II | III | IV | ||
| 28-05-2020 | Year 0 | 0 | 0 | 0 | 0 | 
| 28-05-2021 | Year 1 | 16000 | 23000 | 29000 | 35000 | 
| 28-05-2022 | Year 2 | 16000 | 23000 | 29000 | 35000 | 
| 28-05-2023 | Year 3 | 16000 | 23000 | 29000 | 35000 | 
| 28-05-2024 | Year 4 | 16000 | 23000 | 29000 | 35000 | 
| 28-05-2025 | Year 5 | 16000 | 23000 | 29000 | 35000 | 
| Present Value of Cost | 58000.00 | 68000.00 | 97000.00 | 119000.00 | |
| Present value of Return | 59128.6248 | 84997.4 | 107170.6 | 129343.87 | |
| Benefit to Cost | 1.019 | 1.250 | 1.105 | 1.087 | 
Ranking II>III>IV>I